Jul. 7 at 6:21 PM
$BCTX is already preparing for a potential commercial launch — and Bria-IMT is still in Phase 3 👀
BriaCell just engaged
$CRAI and Kaleio to support commercial strategy, market access evaluation, and brand planning for Bria-IMT as its pivotal Phase 3 metastatic breast cancer study continues. ⚕️
The company says this is a commercial-readiness step tied to potential future commercialization planning, pending successful clinical development and regulatory approvals.
See what Wall Street expects next 👉
https://www.zacks.com/stock/research/BCTX/price-target-stock-forecast?cid=sm-stocktwits-0-price_target-oc-38679&ADID=SYND_STOCKTWITS_TWEET_0_PRICETARGET_OC_38679